TASE:ILCOChemicals
Israel Chemicals (TASE:ILCO) Q1 EPS Surge Tests Bearish Profitability Narratives
Israel Chemicals (TASE:ILCO) opened Q1 2026 with revenue of US$2.0b and basic EPS of US$8.40, putting fresh numbers behind a business that has stayed profitable over the past year. The company has seen quarterly revenue move from US$1.60b in Q4 2024 to US$1.77b in Q1 2025 and up to US$2.02b in Q1 2026, while basic EPS over that stretch shifted from US$4.08 to US$4.67 and then to US$8.40. This sets the stage for investors to focus squarely on how net income converts into margin quality this...